Schedule and Program for Highlights of ASH in Latin America

The following program topics will be presented during the 2020 Highlights of ASH in Latin America.

The 2020 Highlights of ASH in Latin America meeting in Brazil has been postponed to 2021. ASH and the Associacao Brasileira de Hematologia, Hemoterapia, e Terapia Celular decided to reschedule the meeting as a precautionary measure in response to the current outbreak of respiratory illnesses caused by the novel (new) coronavirus (COVID-19). The health and safety of our meeting attendees is ASH’s top priority. Exact dates and locations for the 2021 meeting will be announced soon.

O Highlights of ASH 2020 na América Latina, previsto para acontecer no Brasil entre os dias 3 e 4 de abril, foi adiado para 2021. A ASH e a Associação Brasileira de Hematologia, Hemoterapia, e Terapia Celular (ABHH) decidiram remarcar a reunião como medida de precaução, em resposta ao atual surto de doenças respiratórias causadas pelo novo coronavírus (COVID-19). A saúde e segurança de nossos participantes é prioridade máxima para nós. As datas exatas e locais para a reunião de 2021 serão anunciadas em breve.

Los Highlights of ASH 2020 en América Latina, prevista en Brasil entre el 3 y 4 de abril, se ha reprogramado para 2021. La ASH y la Associação Brasileira de Hematologia, Hemoterapia, e Terapia Celular (ABHH) decidieron reagendar la reunión como medida de precaución, en respuesta al actual coronavirus (COVID-19). La salud y seguridad de nuestros participantes es la máxima prioridad para nosotros. Las fechas exactas y locales para la reunión de 2021 serán anunciadas en breve.

Friday - April 3

7:30 a.m.	Registration and Exhibition Opens
8:15 a.m.	Welcome and Introductions
8:30 a.m.	*Myelodysplastic Syndromes* David P. Steensma, MD Dana-Farber Cancer Institute
9:00 a.m.	*Acute Myeloid Leukemia* James Foran, MD Mayo Clinic Florida
9:30 a.m.	*Acute Lymphoblastic Leukemia* Sarah Tasian, MD Children's Hospital of Philadelphia
10:00 a.m.	Panel Discussion
10:30 a.m.	Coffee Break and Exhibition
11:00 a.m.	*Lymphoma* Nina Wagner Johnston, MD Johns Hopkins University Hospital
11:30 a.m.	*Hematopoietic Stem Cell Transplantation* Stephanie Lee, MD, MPH Fred Hutchinson Cancer Research Center
12:00 noon	Panel Discussion
12:30 p.m.	Lunch with the Experts Session
1:45 p.m.	*Myeloproliferative Neoplasms including Chronic Myeloid Leukemia* Raajit Rampal, MD, PhD Memorial Sloan Kettering
2:15 p.m.	*Disorders of Hemostasis* Ming Y. Lim, MBBCh University of Utah
2:45 p.m.	*Panel Discussion*
3:15 p.m.	Coffee Break and Exhibition
3:45 p.m.	Venous Thromboembolism/Anticoagulation and Its Reversal Prakash Vishnu, MD CHI Franciscan Medical Group
4:15 p.m.	*Special Session on ASH Clinical Practice Guidelines on VTE for Latin America* Ignacio Neumann, MD Pontificia Universidad Católica de Chile Suely Rezende, MD Faculdade de Medicina de Universidade Federal de Minas Gerais
5:00 p.m.	Panel Discussion
5:30 p.m.	Closing Remarks

Saturday - April 4

7:00 a.m.	Highlights of ASH Breakfast Session (ends at 8:30 a.m.)
8:00 a.m.	Registration and Exhibition
8:30 a.m.	Welcome and Introductions
8:45 a.m.	*Sickle Cell Disease: Sickling and other Hemoglobinathies* Kim Smith-Whitley, MD Children's Hospital of Philadelphia
9:15 a.m.	*Acquired Bone Marrow Failure Syndromes* Bart Scott, MD Fred Hutchinson Cancer Research Center
9:45 a.m.	*Iron Deficiency Anemia* Mark Kahn, MD, MBA Tulane University
10:15 a.m.	Panel Discussion
10:45 a.m.	Coffee Break and Exhibition
11:15 a.m.	*How to Drive CAR T* Elizabeth Shpall, MD MD Anderson
11:45 a.m.	*Immune Thrombocytopenic Purpura/Thrombotic Thrombocytopenic Purpura/ Immune Hemolysis/ and Atypical Hemolytic Uremic Syndrome* Hanny Al-Samkari, MD Massachusetts General Hospital
12:15 p.m.	Panel Discussion
12:45 p.m.	Lunch With the Experts Session
2:00 p.m.	*Transfusion Medicine and Apheresis* Lawrence Goodnough, MD Stanford University
2:30 p.m.	*Chronic Lymphocytic Leukemia* Jeremy S. Abramson, MD Massachusetts General Hospital Cancer Center
3:00 p.m.	Myeloma & Plasma Cell Dyscrasia Joseph Mikhael, MD International Myeloma Foundation
3:30 p.m.	Panel Discussion
4:00 p.m.	Closing Remarks and Program Adjournment